New research discovers plan extract to avoid the addiction of morphine

Oct, 2021 - By SMI

Corydalis yanhusuo extract reduces morphine resistance and dependency while also curing opioid overdose.

Over the last two decades, there has been a substantial increase in opioid overdose deaths in the U.S. And other countries. The opioid crisis has only become worse during the COVID-19 pandemic. The proven benefits of YHS, a plant extract called Corydalis yanhusuo, might have an immediate and positive influence on the opioid crisis. The studies were reported in the journal Pharmaceuticals in the October 2021 edition.

Researchers from the University of California are suggesting the use of this medicinal herb to reduce the usage and misuse of opiates. Corydalis extract reduces pain and the harmful consequences of opiate usage in animals. The next stage would be to put it through human testing. The opioid crisis was sparked by the overuse of opioid medications. Repeated opioid doses are necessary for the management of chronic pain. Tolerance, physical dependency, and addiction are the final results.

A viable option is a co-medication that preserves the analgesic advantages of opioids while avoiding their negative side effects. The results of the study demonstrate that when combined with morphine, YHS reduces morphine tolerance, dependence, and addiction. If YHS is taken in conjunction with morphine at the beginning or throughout pain treatment, there will be less demand for morphine and therefore a lower chance of addiction.

Opiate tolerance is critical for opiate users because they must continually increase their opiate intake to achieve the same analgesic effect. This is the cause of opiate overdose. Because YHS reduces opiate tolerance, there is less need to increase opiate use. For ages, YHS has been utilized as an analgesic in Chinese traditional medicine. It is regarded as safe and widely accessible for purchase, both online or as a "botanical" in some grocery shops.